Skip to main content

Becton Dickinson Value Stock - Dividend - Research Selection

Becton dickinson

ISIN: US0758871091 , WKN: 857675

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and other products for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laparoscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women\'s health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience

2025-10-01
BDX partners with Henry Ford Health to deploy BD Rowa Vmax robots, aiming to streamline 24/7 pharmacy access in Michigan.

Beat the Market: 5 Dividend Stocks Chosen by Investing.com’s Warren AI

2025-09-29
Investing.com -- Dividend investors seeking both income and growth potential have compelling options in today’s market, according to Investing.com’s WarrenAI analysis. The AI-powered system has identified five standout dividend stocks across various sectors, combining attractive yields with significant upside potential based on fair value assessments, fundamentals, and technical indicators.

Becton Dickinson Insiders Added US$1.36m Of Stock To Their Holdings

2025-09-29
Quite a few insiders have dramatically grown their holdings in Becton, Dickinson and Company ( NYSE:BDX ) over the past...

Waters Merger Risks Weakening Its Competitive Moat

2025-09-29
Waters' merger with Becton, Dickinson and Company’s Bioscience and Diagnostic Solutions business is a strategic move. Read why WAT stock is a Hold.

Best Dividend Aristocrats For October 2025

2025-09-28
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date. Check out the promising dividend aristocrats right now.

Dividend Champion, Contender, And Challenger Highlights: Week Of September 28

2025-09-26
Read the latest dividend updates for Dividend Champions, Contenders, and Challengers. Track changes, ex-dividend, and pay dates.

Becton Dickinson & Co. stock outperforms competitors on strong trading day

2025-09-26
Becton Dickinson & Co. stock outperforms competitors on strong trading day

RBC starts Becton Dickinson at Sector Perform, sees limited upside until 2027

2025-09-25
Investing.com -- RBC Capital Markets initiated coverage of Becton, Dickinson and Company with a Sector Perform rating and a $211 price target, saying the medical device maker’s growth acceleration is more likely to come after 2026.

Becton Dickinson & Co. stock underperforms Thursday when compared to competitors

2025-09-25
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors

Why BD (BDX) Shares Are Falling Today

2025-09-25
Shares of medical technology company Becton, Dickinson and Company (NYSE:BDX) fell 4.2% in the morning session after RBC Capital initiated coverage on the company with a neutral 'Sector Perform' rating.